Novartis: India Rejects Patent Plea For Cancer Drug Glivec

by
editors
India's Supreme Court has rejected a plea by Novartis to patent an updated version of its cancer drug, Glivec.

 
India's Supreme Court has rejected a plea by Novartis to patent an updated version of its cancer drug, Glivec.
 
The Swiss drugmaker was denied a patent by Indian authorities on the grounds that the new version was only slightly different from the old.
 
 
Read it on BBC